Nucryst Pharmaceuticals, of Akefield, Mass., named Katherine Turner vice president of research and development.

Progen Pharmaceuticals Ltd., of Brisbane, Australia, named Rene Adam, Pei-Jer Chen, Gail Eckhardt, Philip Johnson, Sung-Gye Lee, Ronnie Poon, Myron Schwartz, William Sievert and Tadatoshi Takayama to its international clinical advisory board to support the clinical development and commercialization of PI-88 in the treatment of post-resection liver cancer.